Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-03-10

FDA Approved: METOLAZONE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for metolazone by Sandoz Inc. It is a diuretic used to treat edema and hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METOLAZONE (metolazone)

Snippet

SUPPL AP for METOLAZONE (METOLAZONE)